Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$2.16 - $5.94 $266,731 - $733,512
123,487 Added 106.77%
239,143 $1.07 Million
Q4 2023

Feb 14, 2024

BUY
$1.11 - $2.34 $60,937 - $128,463
54,899 Added 90.36%
115,656 $268,000
Q3 2023

Nov 14, 2023

SELL
$1.06 - $3.91 $133,179 - $491,256
-125,641 Reduced 67.4%
60,757 $77,000
Q2 2023

Aug 14, 2023

SELL
$3.08 - $9.55 $383,592 - $1.19 Million
-124,543 Reduced 40.05%
186,398 $613,000
Q1 2023

May 15, 2023

SELL
$4.0 - $7.02 $464,844 - $815,801
-116,211 Reduced 27.21%
310,941 $1.28 Million
Q4 2022

Feb 14, 2023

BUY
$5.65 - $7.86 $195,625 - $272,144
34,624 Added 8.82%
427,152 $2.5 Million
Q3 2022

Nov 14, 2022

BUY
$4.63 - $8.0 $1.26 Million - $2.18 Million
273,012 Added 228.43%
392,528 $2.65 Million
Q2 2022

Aug 15, 2022

SELL
$2.84 - $5.0 $472,797 - $832,390
-166,478 Reduced 58.21%
119,516 $552,000
Q1 2022

May 16, 2022

BUY
$3.74 - $6.63 $649,570 - $1.15 Million
173,682 Added 154.64%
285,994 $1.14 Million
Q4 2021

Feb 14, 2022

BUY
$5.48 - $9.86 $615,469 - $1.11 Million
112,312 New
112,312 $699,000
Q3 2021

Nov 15, 2021

SELL
$8.56 - $14.47 $173,151 - $292,699
-20,228 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$13.28 - $18.07 $190,568 - $259,304
14,350 Added 244.13%
20,228 $275,000
Q1 2021

May 17, 2021

BUY
$15.31 - $26.52 $31,385 - $54,366
2,050 Added 53.55%
5,878 $95,000
Q4 2020

Feb 16, 2021

SELL
$16.84 - $27.59 $513,569 - $841,412
-30,497 Reduced 88.85%
3,828 $102,000
Q3 2020

Nov 16, 2020

SELL
$16.2 - $25.7 $164,592 - $261,112
-10,160 Reduced 22.84%
34,325 $639,000
Q2 2020

Aug 14, 2020

BUY
$5.24 - $23.4 $160,265 - $715,689
30,585 Added 220.04%
44,485 $1.04 Million
Q1 2020

May 15, 2020

BUY
$4.41 - $9.28 $51,508 - $108,390
11,680 Added 526.13%
13,900 $81,000
Q4 2019

Feb 14, 2020

SELL
$1.45 - $6.73 $3,084 - $14,314
-2,127 Reduced 48.93%
2,220 $13,000
Q3 2019

Nov 14, 2019

SELL
$1.54 - $4.2 $16,533 - $45,091
-10,736 Reduced 71.18%
4,347 $7,000
Q2 2019

Aug 14, 2019

BUY
$3.84 - $6.4 $3,206 - $5,344
835 Added 5.86%
15,083 $61,000
Q1 2019

May 15, 2019

BUY
$3.51 - $7.3 $31,660 - $65,846
9,020 Added 172.53%
14,248 $75,000
Q4 2018

Feb 14, 2019

BUY
$3.45 - $9.72 $18,036 - $50,816
5,228 New
5,228 $21,000
Q3 2018

Nov 14, 2018

SELL
$10.0 - $19.02 $16,160 - $30,736
-1,616 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$14.2 - $22.68 $22,947 - $36,650
1,616 New
1,616 $29,000

Others Institutions Holding MRSN

About Mersana Therapeutics, Inc.


  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $59.3M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.